Dual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 15287-15303

  Liu, Guo Xia ^a   Fang, Gui Qing ^a   Xu, Wei ^b  

^a JINAN STOMATOLOGICAL HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Biomimetic liposomes; Co delivery; DNA; Folate; Hyaluronic acid; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYRIBONUCLEASE I; DNA; FOLIC ACID; HYALURONIC ACID; LIPOSOME; NANOPARTICLE; PACLITAXEL;

ANIMAL; BIOMIMETICS; CELL SURVIVAL; CHEMISTRY; DRUG STABILITY; HEPG2 CELL LINE; HUMAN; METABOLISM; MOUSE; STATIC ELECTRICITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOMIMETICS; CELL SURVIVAL; DEOXYRIBONUCLEASE I; DNA; DRUG STABILITY; FOLIC ACID; HEP G2 CELLS; HUMANS; HYALURONIC ACID; LIPOSOMES; MICE; NANOPARTICLES; PACLITAXEL; STATIC ELECTRICITY;

EID: 84906860752     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150915287     Document Type: Article

References (27)

1. Li, J.; Wang, Y.; Zhu, Y.; Oupický, D. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. J. Control. Release 2013, 172, 589-600.
2. Hu, Q.; Li, W.; Hu, X.; Hu, Q.; Shen, J.; Jin, X.; Zhou, J.; Tang, G.; Chu, P.K. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. Biomaterials 2012, 33, 6580-6591.
3. Jin, X.; Mo, R.; Ding, Y.; Zheng, W.; Zhang, C. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Mol. Pharm. 2013, 11, 145-157.
4. Roy, A.; Singh, M.S.; Upadhyay, P.; Bhaskar, S. Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model. Int. J. Pharm. 2013, 445, 171-180.
5. Gao, L.; Liu, G.; Ma, J.; Wang, X.; Wang, F.; Wang, H.; Sun, J. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells. Colloids Surf. B Biointerfaces 2014, 117, 122-127.
6. Van Vlerken, L.E.; Duan, Z.; Little, S.R.; Seiden, M.V.; Amiji, M.M. Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems. AAPS J. 2010, 12, 171-180.
7. Kirtane, A.R.; Panyam, J. Polymer nanoparticles: Weighing up gene delivery. Nat. Nanotechnol. 2013, 8, 805-806.
8. Faneca, H.; Cardoso, A.L.; Trabulo, S.; Duarte, S.; de Lima, M.C.P. Cationic liposome-based systems for nucleic acid delivery: From the formulation development to therapeutic applications. In Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment; Springer: Berlin, Germany, 2013; pp. 153-184.
9. Govindarajan, S.; Kitaura, K.; Takafuji, M.; Ihara, H.; Varadarajan, K.; Patel, A.B.; Gopal, V. Gene delivery into human cancer cells by cationic lipid-mediated magnetofection. Int. J. Pharm. 2013, 446, 87-99.
10. Choosakoonkriang, S.; Lobo, B.A.; Koe, G.S.; Koe, J.G.; Middaugh, C.R. Biophysical characterization of PEI/DNA complexes. J. Pharm. Sci. 2003, 92, 1710-1722.
11. He, Y.; Nie, Y.; Xie, L.; Song, H.; Gu, Z. P53 mediated apoptosis by reduction sensitive shielding ternary complexes based on disulfide linked PEI ternary complexes. Biomaterials 2014, 35, 1657-1666.
12. Kim, H.; Lee, Y.; Lee, I.H.; Kim, S.; Kim, D.; Saw, P.E.; Lee, J.; Choi, M.; Kim, Y.C.; Jon, S. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin. J. Control. Release 2014, 178, 118-124.
13. Böger, C.; Kalthoff, H.; Goodman, S.L.; Behrens, H.-M.; Röcken, C. Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression. Virchows Arch. 2014, 464, 69-78.
14. Leamon, C.P.; Jackman, A.L. Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam. Horm. 2008, 79, 203-233.
15. Reddy, J.; Allagadda, V.; Leamon, C. Targeting therapeutic and imaging agents to folate receptor positive tumors. Curr. Pharm. Biotechnol. 2005, 6, 131-150.
16. Hilgenbrink, A.R.; Low, P.S. Folate recepto-Mezdiated drug targeting: From therapeutics to diagnostics. J. Pharm. Sci. 2005, 94, 2135-2146.
17. Yang, J.; Huang, L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther. 1998, 5, 380-387.
18. Miao, W.; Shim, G.; Kang, C.M.; Lee, S.; Choe, Y.S.; Choi, H.-G.; Oh, Y.-K. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34, 9638-9647.
19. Lee, T.; Lim, E.K.; Lee, J.; Kang, B.; Choi, J.; Park, H. S.; Suh, J.S.; Huh, Y.M.; Haam, S. Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals. Nanoscale Res. Lett. 2013, 8, 1-9.
20. Ahrens, T.; Assmann, V.; Fieber, C.; Termeer, C.C.; Herrlich, P.; Hofmann, M.; Simon, J.C. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J. Investig. Dermatol. 2001, 116, 93-101.
21. Urbiola, K.; García, L.; Zalba, S.; Garrido, M.J.; de Ilarduya, C.T. Efficient serum-resistant lipopolyplexes targeted to the folate receptor. Eur. J. Pharm. Biopharm. 2013, 83, 358-363.
22. Wang, L.; Su, W.; Liu, Z.; Zhou, M.; Chen, S.; Chen, Y.; Lu, D.; Liu, Y.; Fan, Y.; Zheng, Y.; et al. CD-44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials 2012, 33, 5107-5114.
23. Aranda, C.; Urbiola, K.; Ardoy, A.M.; Fernandez, J.M.G.; Mellet, C.O.; de Ilarduya, C.T. Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo. Eur. J. Pharm. Biopharm. 2013, 85, 390-397.
24. Moret, I.; Esteban Peris, J.; Guillem, V.M.; Benet, M.; Revert, F.; Dasí, F.; Crespo, A.; Aliño, S.F. Stability of PEI-DNA and DOTAP-DNA complexes: Effect of alkaline pH, heparin and serum. J. Control. Release 2001, 76, 169-181.
25. Park, M.R.; Han, K.O.; Han, I.K.; Cho, M.H.; Nah, J.W.; Choi, Y.J.; Cho, C.S. Degradable polyethylenimine-poly (ethylene glycol) copolymers as novel gene carriers. J. Control. Release 2005, 105, 367-380.
26. Shim, G.; Choi, H.W.; Lee, S.; Choi, J.; Yu, Y.H.; Park, D.E.; Choi, Y.; Kim, C.W.; Oh, Y.K. Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes. Mol. Ther. 2013, 21, 816-824.
27. Wang, Y.; Yang, X.; Yang, J.; Wang, Y.; Chen, R.; Wu, J.; Liu, Y.; Zhang, N. Self-assembled nanoparticles of methotrexate conjugated-carboxymethyl chitosan: Preparation, characterization and drug release behavior in vitro. Carbohydr. Polym. 2011, 86, 1665-1670.